HSP90 inhibition improves GIST survival
- PMID: 35750855
- DOI: 10.1038/s41571-022-00659-5
HSP90 inhibition improves GIST survival
Comment on
-
Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial.Ann Oncol. 2022 Sep;33(9):959-967. doi: 10.1016/j.annonc.2022.05.518. Epub 2022 Jun 8. Ann Oncol. 2022. PMID: 35688358 Clinical Trial.
References
Original article
-
- Kurokawa, Y. et al. Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase 3 trial. Ann. Oncol. https://doi.org/10.1016/j.annonc.2022.05.518 (2022) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
